- Home
- Applications
- usa massachusetts
- care clinic
Show results for
Refine by
Care Clinic Product Applications In Usa Massachusetts
32 applications found
Our collective health depends on finding new vaccines and treatments for diseases and illnesses. Clinical trials are pivotal in getting medicines approved to help people in need. We invite you to learn about our clinical trial opportunities and how you may be able to make a ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
When it comes to brain health, you and your loved ones deserve as much clarity and accuracy as possible. That’s why Qynapse is dedicated to providing you and your physician with an objective view of your brain health. ...
ByQynapse based in Paris, FRANCE
Lysosomal diseases are a group of rare, genetic metabolic diseases in which cellular waste products build up in the body. These disorders are generally progressive and there is no cure. Many lysosomal diseases have no FDA-approved ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
Autism is a complex developmental disability that typically appears during the first three years of life and is the result of a neurological disorder that affects the normal functioning of the brain. Autism is characterized by three kinds of symptoms: deficiency in social interaction, difficulties in verbal and non-verbal communication, and severe disabilities in interest areas and activities. In addition, autistic people may develop extreme reactions to noise, touch, or other sensory stimuli. These symptoms are ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
For many years, researchers have investigated cell and gene therapies as potential replacement therapies for severe chronic diseases. Despite major advancements in the field, these approaches carry a number of limitations including immune rejection, limited eligibility, durability and variability challenges, inability to re-dose and high manufacturing costs. To address these drawbacks, we developed our novel Shielded Living Therapeutics™ (SLTx) platform, which we believe has the potential to result in ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
The ability to create large, RF lesions has multiple applications in soft tissue and tumor ablation. For example, there is a clear, unmet need in the market for the treatment of liver cancer. ...
ByThermedical, Inc. based in Waltham, MASSACHUSETTS (USA)
Misdiagnosed Myocardial Ischemia, Heart Attack & Stroke Risk Leads to Poor Outcomes; Myocardial ischemia occurs when blood flow to your heart is reduced, preventing the heart muscle from receiving enough oxygen. This is often the result of plaque buildup inside the artery wall. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated.1 Current non-invasive testing cannot visualize the biology deep inside artery walls where heart ...
ByElucid based in Boston, MASSACHUSETTS (USA)
We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer ...
ByUniversal Diagnostics SL based in Seville, SPAIN
Rare blood disorders are a group of rare genetic disorders where the blood does not clot properly. Existing therapies for blood disorders place a high burden on patients and caregivers, requiring infusions as often as multiple times each week over a patient’s ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
Medica offers a low-cost, easy-to-use, fully automated clinical chemistry analyzer for small to medium-size laboratories. The EasyRA® analyzer is specifically designed to provide high-quality clinical chemistry analysis with low operating ...
ByMedica Corporation based in Bedford, MASSACHUSETTS (USA)
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...
ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)
Anti-psychotic medications are often effective for the positive symptoms of schizophrenia, and allow many patients to lead normal lives. However, many patients suffer from negative symptoms, which include inexpressiveness, deficits in cognitive and emotional skills, and lethargy. To date, the FDA has not approved any drug for the treatment of the negative symptoms of schizophrenia, and from the clinical data available it does not appear as though existing drugs – even new generation drugs – represent a ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
When you have type 2 diabetes, your body isn’t able to properly use insulin to bring glucose into your cells. ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)
Non-invasive, topical skin closure device eliminates unnecessary “track marks” caused by sutures and staples(1,4). Reduces scar-producing tension by evenly distributing forces along the entire length of the wound edges(1,4). Interlaced technology aligns and securely maintains skin edges in the same planar level, promoting optimal ...
ByClozex Medical, Inc. based in Watertown, MASSACHUSETTS (USA)
Ventricular Tachycardia (VT) is a complex condition that has many underlying causes, varying degrees of symptoms, and potentially fatal outcomes if not treated effectively. ...
ByThermedical, Inc. based in Waltham, MASSACHUSETTS (USA)
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
ByQynapse based in Paris, FRANCE
Non-invasive, topical skin closure device eliminates unnecessary “track marks” caused by sutures and ...
ByClozex Medical, Inc. based in Watertown, MASSACHUSETTS (USA)
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in a person’s mood, energy, and ability to function. Different from the normal ups and downs that everyone goes through, the symptoms of bipolar disorder are severe. They can result in damaged relationships, poor job or school performance, and even suicide. About 5.7 million American adults or about 2.6 percent of the population aged 18 and older in any given year, have bipolar ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Wound infections are on the rise affecting Millions of Americans and costing Billions in healthcare expenditure. According to the Centers for Disease Control and Prevention Report, antibiotic-resistant bacteria will cause serious infections in millions of Americans each year, resulting in patient deaths, morbidity, serious complications, and huge economic losses. ...
ByGel4Med, Inc. based in Allston, MASSACHUSETTS (USA)